Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Rami Komrokji is the Vice Chair of the Malignant Hematology Department and the Lead Clinical Investigator for the MDS Program at the Moffitt Cancer Center, Tampa, Florida. He is a senior member of the Malignant Hematology and Experimental Therapeutics Program at the Moffitt Cancer Center, and a Professor in Medicine & Oncologic Sciences at the College of Medicine, at the University of South Florida in Tampa, Florida.
After earning a medical degree from the Jordan University School of Medicine, Dr. Komrokji completed an internship and residency at Case Western University, St. Vincent Program. He then completed a fellowship at Strong Memorial Hospital, University of Rochester, in Hematology/Oncology and Hematopoietic Stem Cell Transplantation. Dr. Komrokji is a member of the American Society of Hematology, American Society of Clinical Oncology. He was President of the American VA Hematology/Oncology Association. Dr. Komrokji’s research interests are in Phase I and II clinical trials, and in the outcome research in hematologic malignancies with focus on myeloid neoplasms. His clinical interests are myelodysplastic syndromes (MDS), acute leukemias and myeloproliferative neoplasms.